Related Experiment Videos
[Percutaneous transluminal laser angioplasty]
1Department of Radiology, Hirosaki University School of Medicine.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica
|March 25, 1992
Summary
Percutaneous transluminal laser angioplasty (PTLA) offers a high success rate for peripheral arterial occlusive lesions. This laser angioplasty technique demonstrates excellent 5-year patency, improving outcomes compared to conventional angioplasty.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Medical Technology
Background:
- Peripheral arterial occlusive disease (PAOD) significantly impacts patient quality of life, often causing intermittent claudication.
- Conventional angioplasty has limitations in treating complex lesions, including long occlusions and severe stenosis.
Observation:
- A study evaluated 63 peripheral arterial occlusive lesions in 43 patients using percutaneous transluminal laser angioplasty (PTLA).
- Lesions included iliac (44.4%), femoropopliteal (47.6%), and below-knee arteries (8.0%), with 85.7% showing >70% stenosis and 30.2% complete occlusions.
- A Nd:YAG laser was employed for plaque vaporization, followed by balloon angioplasty.
Findings:
- The initial success rate for PTLA was 85.7%.
- The 5-year cumulative patency rate was 88.4% overall, with specific rates of 88.7% for iliac, 86.1% for femoropopliteal, and 100% for below-knee arteries.
- Five-year patency for stenosis was high (91.0% iliac, 92% femoropopliteal), and 81% for femoropopliteal occlusions.
Implications:
- PTLA demonstrates a promising improvement in long-term vascular patency compared to conventional angioplasty.
- This technique offers a viable option for treating complex peripheral arterial occlusive lesions.
- Further research may explore optimizing laser parameters and patient selection for enhanced PTLA outcomes.